Marksans Pharma inks pact to acquire 100% stake in Access Healthcare for Medical Products
25th Apr 2022

Marksans Pharma has signed a share purchase agreement to acquire a 100% stake in Access Healthcare for Medical Products L.L.C, a Dubai-based front-marketing and promotion company. This transaction was approved by the Board of Directors of the company on April 23, 2022.

This deal will enable Marksans to use the front-end sales and marketing infrastructure of Access Healthcare for marketing its products manufactured in the India, UK, and USA regions. It will bolster Marksans' presence in the Middle East and North African regions by leveraging Access Health's knowledge of local business cultures and access to a network of partners and distributors in those regions. The shareholders of Access Healthcare will receive a cash consideration of AED 13 Million (Rs 21.7 crore) on closure of the transaction, which is subject to regulatory approvals. The transaction will be funded from internal accruals.

Marksans Pharma together with its subsidiaries operates as an integrated international pharmaceutical company. The company’s business is distribution of pharmaceutical products.